Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Ipsen dives into $1.8B Skyhawk pact to fire up RNA modulator R&D
Ipsen has landed the chance to option two candidates that could benefit from its “neuroscience expertise in movement disorders.”
Nick Paul Taylor
Apr 22, 2024 7:01am
Sponsored
Cloud-Based Technology Supports Complex Supply Chains
Apr 22, 2024 8:00am
Daily aspirin use may limit spread of colorectal tumor cells
Apr 23, 2024 3:50am
New immunotherapy drug design ups survival in mice with cancer
Apr 23, 2024 3:40am
Sanofi nails phase 3 LUNA landing, sparking race to regulators
Apr 23, 2024 2:23am
Labcorp, Quest add new blood tests for Alzheimer's, brain damage
Apr 22, 2024 2:17pm
Medtech News
GE HealthCare launches voice-activated, AI-powered ultrasounds
Apr 22, 2024 11:00am
FDA OKs Lumicell system for highlighting residual breast cancer
Apr 19, 2024 11:08am
Merck KGaA rolls out ‘all-in-one’ CHO genetic stability assay
Apr 18, 2024 4:05pm
Bruker brokers $392M deal for frayed NanoString
Apr 18, 2024 11:24am
See More Medtech News